bioMérieux Balance Sheet Health
Financial Health criteria checks 6/6
bioMérieux has a total shareholder equity of €3.8B and total debt of €370.2M, which brings its debt-to-equity ratio to 9.9%. Its total assets and total liabilities are €5.3B and €1.5B respectively. bioMérieux's EBIT is €569.0M making its interest coverage ratio 172.4. It has cash and short-term investments of €352.4M.
Key information
9.9%
Debt to equity ratio
€370.20m
Debt
Interest coverage ratio | 172.4x |
Cash | €352.40m |
Equity | €3.75b |
Total liabilities | €1.51b |
Total assets | €5.26b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EYWN's short term assets (€2.2B) exceed its short term liabilities (€1.1B).
Long Term Liabilities: EYWN's short term assets (€2.2B) exceed its long term liabilities (€419.7M).
Debt to Equity History and Analysis
Debt Level: EYWN's net debt to equity ratio (0.5%) is considered satisfactory.
Reducing Debt: EYWN's debt to equity ratio has reduced from 25.9% to 9.9% over the past 5 years.
Debt Coverage: EYWN's debt is well covered by operating cash flow (120.3%).
Interest Coverage: EYWN's interest payments on its debt are well covered by EBIT (172.4x coverage).